The Taiwan Food and Drug Administration (TFDA) announced Wednesday that two measures have been implemented to increase intravenous (IV) fluid supplies after a halt in production by Taiwan's major saline supplier sparked concerns about a shortage of the medical resource crucial for surgery.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
China Airlines wins top honors at APEX awards
11/26/2024 11:23 PM - Politics
New labor minister visits branch where worker committed suicide
11/26/2024 11:08 PM - Politics
President Lai reiterates commitment to strengthen Taiwan's defense
11/26/2024 11:04 PM - Society
Group calls on MOL to axe employment stabilization fee
11/26/2024 10:45 PM - Society
Norwegian man indicted for marijuana possession during Taiwan transit
11/26/2024 10:25 PM